89 related articles for article (PubMed ID: 300541)
1. Pharmacokinetics of oxazepam in healthy volunteers.
Alván G; Siwers B; Vessman J
Acta Pharmacol Toxicol (Copenh); 1977 Jan; 40 Suppl 1(1):40-51. PubMed ID: 300541
[TBL] [Abstract][Full Text] [Related]
2. Oxazepam disposition in uremic patients.
Odar-Cederlöf I; Vessman J; Alván G; Sjöqvist F
Acta Pharmacol Toxicol (Copenh); 1977 Jan; 40 Suppl 1(1):52-62. PubMed ID: 300542
[TBL] [Abstract][Full Text] [Related]
3. Comparative bioavailability of oral dosage forms of oxazepam--correlation with in vitro dissolution rate.
Pilbrant A; Glenne PO; Sundwall A; Vessman J; Wretlind M
Acta Pharmacol Toxicol (Copenh); 1977 Jan; 40 Suppl 1(1):7-15. PubMed ID: 322447
[TBL] [Abstract][Full Text] [Related]
4. Effect of high-dose vitamin C on the steady-state pharmacokinetics of the protease inhibitor indinavir in healthy volunteers.
Slain D; Amsden JR; Khakoo RA; Fisher MA; Lalka D; Hobbs GR
Pharmacotherapy; 2005 Feb; 25(2):165-70. PubMed ID: 15767232
[TBL] [Abstract][Full Text] [Related]
5. Disposition of three benzodiazepines after single oral administration in man.
Wretlind M; Pilbrant A; Sundwall A; Vessman J
Acta Pharmacol Toxicol (Copenh); 1977 Jan; 40 Suppl 1(1):28-39. PubMed ID: 15399
[TBL] [Abstract][Full Text] [Related]
6. Kinetics and dynamics of single doses of oxazepam in the elderly: implications of absorption rate.
Dreyfuss D; Shader RI; Harmatz JS; Greenblatt DJ
J Clin Psychiatry; 1986 Oct; 47(10):511-4. PubMed ID: 3759915
[TBL] [Abstract][Full Text] [Related]
7. First pass conjugation and enterohepatic recycling of oxazepam in dogs; intravenous tolerance of oxazepam in propylene glycol.
Alván G; Jönsson M; Sundwall A; Vessman J
Acta Pharmacol Toxicol (Copenh); 1977 Jan; 40 Suppl 1(1):16-27. PubMed ID: 300540
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of ciprofloxacin: intravenous and increasing oral doses.
Bergan T; Thorsteinsson SB; Solberg R; Bjornskau L; Kolstad IM; Johnsen S
Am J Med; 1987 Apr; 82(4A):97-102. PubMed ID: 3578334
[TBL] [Abstract][Full Text] [Related]
9. Oxazepam kinetics: effects of age and sex.
Greenblatt DJ; Divoll M; Harmatz JS; Shader RI
J Pharmacol Exp Ther; 1980 Oct; 215(1):86-91. PubMed ID: 7452494
[TBL] [Abstract][Full Text] [Related]
10. Multiple-dose pharmacokinetics of ofloxacin, a new broad-spectrum antimicrobial agent.
Dagrosa EE; Verho M; Malerczyk V; de Looze S; Hajdú P; Toyodera K
Clin Ther; 1986; 8(6):632-45. PubMed ID: 3466701
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of the gastrokinetic agent mosapride citrate after single and multiple oral administrations in healthy subjects.
Sakashita M; Yamaguchi T; Miyazaki H; Sekine Y; Nomiyama T; Tanaka S; Miwa T; Harasawa S
Arzneimittelforschung; 1993 Aug; 43(8):867-72. PubMed ID: 8216445
[TBL] [Abstract][Full Text] [Related]
12. Multiple oral doses of diazepam, oxazepam and phenobarbital to dogs--behavioural effects and correlation with antipyrine half-life.
Albanus L; Jönsson M; Sparf B
Acta Pharmacol Toxicol (Copenh); 1977 Jan; 40 Suppl 1(1):63-9. PubMed ID: 300543
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of chlormadinone acetate following single and multiple oral dosing of chlormadinone acetate (2 mg) and ethinylestradiol (0.03 mg) and elimination and clearance of a single dose of radiolabeled chlormadinone acetate.
Terlinden R; Uragg H; Göhler K; Kneip C
Contraception; 2006 Sep; 74(3):239-44. PubMed ID: 16904418
[TBL] [Abstract][Full Text] [Related]
14. Dose related pharmacokinetics of ofloxacin in healthy volunteers.
Immanuel C; Hemanthkumar AK; Gurumurthy P; Venkatesan P
Int J Tuberc Lung Dis; 2002 Nov; 6(11):1017-22. PubMed ID: 12475149
[TBL] [Abstract][Full Text] [Related]
15. The pharmacokinetic profile of oxazepam.
Alván G; Odar-Cederlöf I
Acta Psychiatr Scand Suppl; 1978; (274):47-55. PubMed ID: 282777
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and pharmacodynamics of epoetin delta in two studies in healthy volunteers and two studies in patients with chronic kidney disease.
Smith WB; Dowell JA; Pratt RD
Clin Ther; 2007 Jul; 29(7):1368-80. PubMed ID: 17825688
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteers.
Bergman AJ; Stevens C; Zhou Y; Yi B; Laethem M; De Smet M; Snyder K; Hilliard D; Tanaka W; Zeng W; Tanen M; Wang AQ; Chen L; Winchell G; Davies MJ; Ramael S; Wagner JA; Herman GA
Clin Ther; 2006 Jan; 28(1):55-72. PubMed ID: 16490580
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of oxazepam following multiple administration in volunteers and patients with chronic renal disease.
Busch U; Molzahn M; Bozler G; Koss FW
Arzneimittelforschung; 1981; 31(9):1507-11. PubMed ID: 7197965
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic and pharmacodynamic assessments of the dipeptidyl peptidase-4 inhibitor PHX1149: double-blind, placebo-controlled, single- and multiple-dose studies in healthy subjects.
O'Farrell AM; van Vliet A; Abou Farha K; Cherrington JM; Campbell DA; Li X; Hanway D; Li J; Guler HP
Clin Ther; 2007 Aug; 29(8):1692-705. PubMed ID: 17919550
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and pharmacodynamics of single and multiple oral doses of a novel 5-lipoxygenase inhibitor (ABT-761) in healthy volunteers.
Wong SL; Drajesk J; Chang M; Lanni C; Witt G; Hansen R; Awni WM
Clin Pharmacol Ther; 1998 Mar; 63(3):324-31. PubMed ID: 9542476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
